Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 1Margins of Excision 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Esophageal Diseases 1

Interventions

Surveys and Questionnaires 18Blood Specimen Collection 16Specimen Handling 12Observation 6Magnetic Resonance Spectroscopy 6Surgical Procedures, Operative 5Radiotherapy 5trastuzumab deruxtecan 4ribociclib 4darolutamide 4Standard of Care 4Patient Reported Outcome Measures 4Letrozole 4Data Collection 4Cryosurgery 4Breath Tests 4Tomography, X-Ray Computed 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Biopsy 3Anastrozole 3lorlatinib 2cemiplimab 2atezolizumab 2Ultrasonography 2Trastuzumab 2Staining and Labeling 2Restraint, Physical 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Esophagectomy × 30 days × Clear all
NCT01927016 2026-05-14

FREGAT I

University Hospital, Lille

Completed
2,944 enrolled
Gastrointestinal

Esophageal Diseases, Esophageal Neoplasms

NCT07567716 2026-05-05

Infiltration Pattern of Locally Advanced ESCC

Shanghai Chest Hospital

Enrolling by invitation
30 enrolled
Gastrointestinal

Margins of Excision, Esophageal Squamous Cell Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡